[Federal Register Volume 78, Number 122 (Tuesday, June 25, 2013)]
[Notices]
[Pages 38099-38100]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-15107]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Notice of Intent To Grant An Exclusive License

AGENCY: Office of Research and Development, Department of Veterans 
Affairs.

ACTION: Notice of intent.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Department of Veterans Affairs 
(VA), Office of Research and Development (ORD), intends to grant to 
Somahlution, Inc., a Delaware corporation, doing business at 3401 
Fiechtner Drive, Fargo, North Dakota 58103, USA, an exclusive license 
to practice the following patent: U.S. Patent No. 6,569,615, 
``Composition and Methods for Tissue Preservation,'' issued May 27, 
2003. Copies of the published patent may be obtained from the U.S. 
Patent and Trademark Office at www.uspto.gov.

DATES: Comments must be received within 15 days from the date of this 
published Notice.

ADDRESSES: Written comments may be submitted through 
www.regulations.gov; by mail or hand-delivery to the Director, 
Regulations Management (02REG), Department of Veterans Affairs, 810 
Vermont Avenue NW., Room 1068, Washington, DC 20420; or by fax to (202) 
273-9026. Copies of comments received will be available for public 
inspection in the Office of Regulation Policy and Management, Room 
1063B, between the hours of 8:00 a.m. and 4:30 p.m., Monday through 
Friday (except holidays). Call (202) 461-4902 for an appointment. (This 
is not a toll-free number.) In addition, during the comment period, 
comments may be viewed online through the Federal Docket Management 
System (FDMS) at http://www.regulations.gov.

FOR FURTHER INFORMATION CONTACT: Director of Technology Transfer 
Program, Office of Research and Development (10P9TT), Department of 
Veterans Affairs, 810 Vermont Avenue NW., Washington, DC 20420, (202) 
443-5640. (This is not a toll-free number.)

SUPPLEMENTARY INFORMATION: It is in the public interest to so license 
these inventions to Somahlution, Inc. in order to facilitate the 
development and commercialization of new and useful

[[Page 38100]]

means for ``in situ'' and ``ex vivo'' preservation of tissues and 
organs. The prospective exclusive license will be royalty-bearing and 
will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 
404.7. The prospective exclusive license may be granted, unless VA ORD 
receives written evidence and argument within 15 days from the date of 
this published Notice, which establishes that the grant of the license 
would not be consistent with the requirements of 35 U.S.C. 209 and 37 
CFR 404.7.

    Approved: June 11, 2013.
Jose D. Riojas,
Interim Chief of Staff, Department of Veterans Affairs.
[FR Doc. 2013-15107 Filed 6-24-13; 8:45 am]
BILLING CODE P